112 related articles for article (PubMed ID: 1528027)
1. Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection.
Burd RS; Raymond CS; Dunn DL
J Surg Res; 1992 Jun; 52(6):537-42. PubMed ID: 1528027
[TBL] [Abstract][Full Text] [Related]
2. Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide.
Akagawa G; Abe S; Yamaguchi H
J Infect Dis; 1995 Jun; 171(6):1539-44. PubMed ID: 7769289
[TBL] [Abstract][Full Text] [Related]
3. Anti-lipopolysaccharide monoclonal antibodies inhibit macrophage TNF messenger RNA synthesis in vitro.
Battafarano RJ; Burd RS; Cody CS; Kellogg TA; Raymond CS; Ratz CA; Dunn DL
J Surg Res; 1993 Apr; 54(4):342-8. PubMed ID: 8331928
[TBL] [Abstract][Full Text] [Related]
4. Antibody immunotherapy of gram-negative bacterial sepsis in an immunosuppressed animal model.
Dunn DL
Transplantation; 1988 Feb; 45(2):424-9. PubMed ID: 3278438
[TBL] [Abstract][Full Text] [Related]
5. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis.
Klaerner HG; Uknis ME; Acton RD; Dahlberg PS; Carlone-Jambor C; Dunn DL
J Surg Res; 1997 Jul; 70(2):161-5. PubMed ID: 9245566
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antibacterial drugs in mice with complex infection by Candida albicans and Escherichia coli.
Ikeda T; Suegara N; Abe S; Yamaguchi H
J Antibiot (Tokyo); 1999 Jun; 52(6):552-8. PubMed ID: 10470680
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
[TBL] [Abstract][Full Text] [Related]
8. Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody.
Dunn DL; Bogard WC; Cerra FB
Arch Surg; 1985 Jan; 120(1):50-3. PubMed ID: 3917664
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
Dunn DL; Bogard WC; Cerra FB
Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
[TBL] [Abstract][Full Text] [Related]
10. An immunoprotective monoclonal antibody to lipopolysaccharide.
Kirkland TN; Ziegler EJ
J Immunol; 1984 May; 132(5):2590-2. PubMed ID: 6201551
[TBL] [Abstract][Full Text] [Related]
11. Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.
Hoffman WD; Danner RL; Quezado ZM; Banks SM; Elin RJ; Hosseini JM; Natanson C
Infect Immun; 1996 Feb; 64(2):406-12. PubMed ID: 8550184
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of splenic macrophage tumor necrosis factor alpha secretion in vivo by antilipopolysaccharide monoclonal antibodies.
Battafarano RJ; Burd RS; Kurrelmeyer KM; Ratz CA; Dunn DL
Arch Surg; 1994 Feb; 129(2):179-80. PubMed ID: 8304828
[TBL] [Abstract][Full Text] [Related]
13. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
14. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
Lee JW; Paape MJ; Zhao X
Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors.
Acton RD; Dahlberg PS; Uknis ME; Klaerner HG; Fink GS; Norman JG; Dunn DL
Arch Surg; 1996 Nov; 131(11):1216-21. PubMed ID: 8911263
[TBL] [Abstract][Full Text] [Related]
16. Implications of endotoxin contamination in the evaluation of antibodies to lipopolysaccharides in a murine model of gram-negative sepsis.
Chong KT; Huston M
J Infect Dis; 1987 Nov; 156(5):713-9. PubMed ID: 3309071
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection.
Dunn DL; Ewald DC; Chandan N; Cerra FB
Arch Surg; 1986 Jan; 121(1):58-62. PubMed ID: 3942500
[TBL] [Abstract][Full Text] [Related]
18. Treatment of toxic shock syndrome with endotoxin-neutralizing antibody.
Priest BP; Schlievert PM; Dunn DL
J Surg Res; 1989 Jun; 46(6):527-31. PubMed ID: 2733415
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
Ghiselli R; Silvestri C; Cirioni O; Kamysz W; Orlando F; Calcinari A; Kamysz E; Casteletti S; Rimini M; Tocchini M; Giacometti A; Guerrieri M
J Surg Res; 2011 Dec; 171(2):726-33. PubMed ID: 20605608
[TBL] [Abstract][Full Text] [Related]
20. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
